BioSyent Inc. (OTCMKTS:BIOYF) Sees Significant Drop in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a drop of 69.2% from the October 31st total of 1,300 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 0.1 days.

BioSyent Stock Performance

BIOYF stock traded up $0.02 on Wednesday, reaching $8.05. The company’s stock had a trading volume of 520 shares, compared to its average volume of 2,237. The business has a fifty day simple moving average of $8.03 and a two-hundred day simple moving average of $7.54. BioSyent has a 12-month low of $5.93 and a 12-month high of $8.90.

BioSyent Cuts Dividend

The business also recently declared a dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a dividend of $0.0322 per share. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, November 29th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.